Orion Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,500	Closed	-$5.34K	–	489
2025 Q4	$5.34K	Hold	1,500	–	–	﹤0.01%	425
2025 Q3	$13.3K	Hold	1,500	–	–	﹤0.01%	369
2025 Q2	$13.8K	Hold	1,500	–	–	0.01%	345
2025 Q1	$12.9K	Hold	1,500	–	–	0.01%	341
2024 Q4	$16.1K	Sell	1,500 -10,000	-87%	-$76.9K	0.01%	338
2024 Q3	$65.3K	Buy	11,500 +10,000	+667%	+$57.7K	0.03%	128
2024 Q2	$6.33K	Sell	1,500 -7,000	-82%	-$28.3K	﹤0.01%	368
2024 Q1	$43.3K	Hold	8,500	–	–	0.02%	260
2023 Q4	$79.1K	Sell	8,500 -500	-6%	-$3.44K	0.05%	190
2023 Q3	$59K	Buy	+9,000	New	+$71.6K	0.04%	203
2023 Q2	–	Sell	-9,500	Closed	-$81.4K	–	167
2023 Q1	$81.4K	Hold	9,500	–	–	0.05%	175
2022 Q4	$88K	Hold	9,500	–	–	0.06%	157
2022 Q3	$98K	Hold	9,500	–	–	0.08%	147
2022 Q2	$95K	Hold	9,500	–	–	0.07%	153
2022 Q1	$117K	Hold	9,500	–	–	0.07%	158
2021 Q4	$165K	Sell	9,500 -1,000	-10%	-$19K	0.09%	131
2021 Q3	$188K	Buy	10,500 +200	+2%	+$3.98K	0.11%	116
2021 Q2	$235K	Sell	10,300 -500	-5%	-$7.41K	0.15%	101
2021 Q1	$161K	Sell	10,800 -200	-2%	-$2.18K	0.11%	112
2020 Q4	$59K	Buy	+11,000	New	+$58K	0.04%	147